Back

Welcome and introduction: the origin and evolution of the disease.

22 May 2022 (09:40 - 09:49)
Organised by:
Congress Presentation Part of: New targets to enhance survival and outcomes in hATTR amyloidosis Clinical Open Access Heart Failure 2022

About the speaker

Photo
Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)

3 More presentations in this session

Presentation thumbnail
Treatment strategies targeting TTR amyloid in hATTR amyloidosis (a multi-system disease).
Doctor H. Nienhuis (Groningen, NL)
Slides Video
Presentation thumbnail
Update on RNAi therapy in hATTR amyloidosis.
Doctor P. Garcia-Pavia (Majadahonda, ES)
Slides Video
Presentation thumbnail
Discussion and closing remarks.
Professor T. Damy (Creteil, FR) Doctor P. Garcia-Pavia (Majadahonda, ES) Doctor H. Nienhuis (Groningen, NL)
Video

Access the full session

Session thumbnail
New targets to enhance survival and outcomes in hATTR amyloidosis
Video

The Event

Event poster

Heart Failure 2022

22 May 2022 09:40 CET
You may be interested in
thumbnail
Congress Presentation
The role of TTR in ATTR-CM disease and treatment
2 September 2024
thumbnail
Congress Presentation
New frontiers in the management of amyloid heart disease.
22 May 2022
thumbnail
Congress Session
Decoding hATTR: exploring disease progression and management strategies
12 May 2024
thumbnail
Congress Presentation
Improving outcomes in ATTRv amyloidosis through timely cardiac imaging
11 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources